Home › Drug Codes › CPT Codes › 90684 · CAPVAXIVE
Updated July 1st, 2026

CAPVAXIVE CPT Vaccine Code: 90684

Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use

Login to unlock all benchmarks
Medicare Payment Limit ?
$344.252
per dose
CDC Cost / Dose ?
$•••.••
Login to view
Private Sector Cost / Dose ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →
Medicare Coverage Medicare Part B covers CAPVAXIVE as a preventive vaccine — the Part B deductible and coinsurance do not apply.

Vaccine & Product Overview

HCPCS Descriptor Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use
Manufacturer Merck Sharp & Dohme Corp
Route of Administration Intramuscular
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About CAPVAXIVE

Capvaxive is a medication aligned to the HCPCS CPT Drug Code: 90684 for billing, pricing, and reimbursement purposes in the United States. It is a Vaccine drug administered via the intramuscular route and manufactured by Merck Sharp & Dohme Corp.

According to CMS Drug Use Information: This vaccine is used to help prevent pneumococcal disease, an infection caused by a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infections or other more serious infections (such as pneumonia, meningitis, blood infection). Vaccination is the best way to protect against this disease. This vaccine works by increasing the body's natural defense (immunity) against the bacteria. Vaccines may not fully protect everyone who receives them.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

1 NDC package is crosswalked to 90684. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CAPVAXIVE Pricing & Reimbursement

90684 Private Payer Reimbursement
$343.15 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

CAPVAXIVE Vaccine Administration Codes

Medicare bills the administration of CAPVAXIVE with HCPCS code G0009, and allows simplified roster billing when vaccinating multiple patients. The CPT codes below apply to non-Medicare payers.

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

Code Description
G0009 Administration of pneumococcal vaccine (Medicare)
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472 Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

CAPVAXIVE Medically Unlikely Edits (MUE)

The most billing units of 90684 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 ea.

Practitioner Office & Hospital Outpatient
1 unit / day
Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

CAPVAXIVE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Invasive disease caused by Streptococcus pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B Pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B
Drug Class
Actively Acquired Immunity [PE]Inactivated Pneumococcal Vaccine [EPC]Pneumococcal Vaccines [CS]VaccinesInactivated [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Capvaxive?
Billing and coding information for CAPVAXIVE can be found through MERCK SHARP & DOHME. Visit Here →
Are there any available patient assistance programs for Capvaxive?
CAPVAXIVE patient assistance information can be found through MERCK SHARP & DOHME. Visit Here →
Where can I find Capvaxive prescribing information?
Capvaxive prescribing information can be found at the link below. Visit Here →
Is there available side effect information for Capvaxive?
Side effect information for Capvaxive can be found through Medline Plus at the link below. Visit Here →
Does billing CAPVAXIVE require JZ/JW wastage modifiers?
CMS does not include CAPVAXIVE (90684) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90684. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.